Prestige Wealth Management Group LLC Cara Therapeutics, Inc. Transaction History
Prestige Wealth Management Group LLC
- $456 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding CARA
# of Institutions
10Shares Held
826KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.56 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$193,2310.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$96,3830.0% of portfolio
-
Rothschild Investment Corp10.6KShares$50,6680.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$42,2210.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $257M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...